AIMP2 and cancer: Other than DX2, no genetic alterations of AIMP2 is known to be associated with human cancers, although a homozygotic nonsense mutation of AIMP2 has been reported to be associated with hypomyelinating leukodystrophy-17, an autosomal recessive neurodevelopmental disorder [13].